Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Phytochemical analysis and biological effects of Zingiber cassumunar extract and three phenylbutenoids: targeting NF-κB, Akt/MAPK, and caspase-3 pathways

Fig. 6

Effect of compound D, compound D acetate, DMPBD, and PE on p65 NF-κB translocation in LPS-inflamed RAW264.7 macrophages. Immunofluorescence staining for NF-κB p65 was observed under fluorescence microscopy after treatment with all tested compounds in the presence and absence of LPS. Nuclei were visualized using Hoechst 33342. CD: (E)-1-(3,4-dimethoxyphenyl)but-3-en-1-ol (compound D), DA: (E)-1-(3,4-dimethoxyphenyl)but-3-en-1-yl acetate (compound D acetate), DMPBD: (E)-(3,4-dimethoxyphenyl)butadiene, PE: phenylbutenoid extract, Dex: dexamethasone, LPS: lipopolysaccharide

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us